×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

Regulatory Affairs Services In India

Regulatory Affairs Consulting Services in India

Artixio helps life sciences companies with regulatory affairs services in India—understanding what needs to be done, preparing the right documentation, and managing the approval steps from start to finish.

India’s Leading Regulatory Affairs Consulting Partner

India’s healthcare industry has grown into one of the world’s major hubs, driven by government incentives, rising R&D investments, and a strong demand for affordable therapies. As the domestic pharmaceutical sector—currently valued at over $50 billion—heads toward a projected $130 billion by 2030, and the need for reliable regulatory affairs consultancy and compliant market-entry strategies has never been higher.

Although the scale and opportunity are growing, product registration in India remains complex. It involves coordination between central and state authorities, multiple legislations, and alignment with global standards like ICH, WHO GMP, and ISO. As a regulatory affairs company in India, Artixio helps simplify this process with clear guidance and hands-on support.

Regulatory Authorities in India

Authority Scope
Central Drugs Standard Control Organization (CDSCO) Central authority for new drug approvals, clinical trials, import licenses, and post-market surveillance.
Drug Controller General of India (DCGI) Heads CDSCO and leads national policy for drugs and medical devices.
State Drug Licensing Authorities (SLAs) Approve manufacturing and sales licenses at state level.
FSSAI (Food Safety & Standards Authority of India) Regulates food supplements and nutraceuticals.

Regulatory Affairs Process in India

To legally market regulated products in India, companies must follow a structured approval process. While the process varies by product type, it generally involves the following steps:
Regulatory Affairs Process In India​
Step 1 - Product Classification
Classifying a product is necessary to determine the documentation and regulatory approval pathway. Examples include:
Step 2 - Appointment of Authorized Indian Agent (For Imports)
It is essential to appoint an authorised Indian agent for foreign manufacturers intending to market products in India. The Indian agent acts as a local liaison with regulatory authorities and is responsible for compliance.
Step 3 - Documentation and Dossier Preparation
Proper dossier preparation is important to avoid delays in product approval. Companies must prepare regulatory dossiers, which include:
Step 4 - Clinical Trial Authorization
For new drugs, vaccines, or innovative biologics, receive the clinical trial approval from CDSCO before marketing. Initial CTA approvals take 45 – 90 days from submission, if complete.
Step 5 - Submission of Application for Product Approval
The application for registration or marketing authorization is submitted to the relevant authority, typically via the SUGAM portal.
Step 6 - Review and Evaluation by Regulatory Authorities
After the submission, the application is reviewed for:
Step 7 - Product Approval & Post-Market Obligations

Once approved, the company must:

Artixio offers complete regulatory affairs consulting services in India, helping global healthcare companies launch products with confidence and full regulatory clarity.

Why Choose Artixio for CDSCO Regulatory Affairs Services?

dossiers successfully filed with CDSCO
ISO 9001:2015 certified documentation workflows
End to End product lifecycle support and renewals
Real-time tracking & submission support via eCTD & SUGAM portals

Are You Launching Your Product in India?

Artixio helps with the end-to-end seamless product registration process.We help with local insight, regulatory accuracy, and full-cycle support and ensure that your products enter the market without delays or compliance risks. Connect with our regulatory affairs consultant in India today for expert guidance and swift market entry.

FAQs

Are CTD/eCTD formats accepted in India?
Yes, CTD is accepted ( not mandatory). eCTD submissions are preferred through the SUGAM online portal.
Manufacturing licenses are granted at the state level. However, import and marketing authorizations are handled centrally by CDSCO.
Registrations (Marketing Authorizations) are typically valid for 5 years, after which a renewal must be filed at least six months before expiration.
No, while prior approvals from USFDA, EMA, or PMDA can support your application and may help secure a waiver for local clinical trials, you still need to submit a full dossier to CDSCO for independent review under Indian regulations.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Regulatory Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

CDSCO Simplifies Subsequent Importer Process for Medical Devices & IVDs

CDSCO Simplifies Subsequent Importer

India’s regulatory authority, the Central Drugs Standard Control Organization (CDSCO), has published an important...

December 1, 2025
CDSCO Medical Device Approval Cost & Fee Structure

CDSCO Medical Device Approval

Central Drug Standard Control Organization (CDSCO) is the regulatory authority that regulates Medical Devices...

December 1, 2025
IVD Medical Devices Registration & Approval In India

IVD Medical Devices Registration

IVDs in India are regulated as drugs under Section 3(b)(i) and 3(b)(iv) of the...

December 2, 2025